HLSQ — Tessera Defense and Homeland Security Share News
0.000.00%
Brief: Biomx Announces Closing Of The Acquisition Of Adaptive Phage Therapeutics And Concurrent $50 Million Financing
U.S. RESEARCH ROUNDUP-Highpeak Energy, Nordstrom, Victoria's Secret & Co
Brief: BiomX To Merge With Biotechnology Company Adaptive Phage Therapeutics
Brief: Biomx Inc Entered Into An At The Market Offering Agreement
Brief: Biomx Files For Mixed Shelf Offering Of Up To $150 Million
Brief: Biomx Announces Positive Topline Results From Part 2 Of The Phase 1B/2A Trial Evaluating Bx004
Brief: BiomX Appoints Edward L. Williams to its Board of Directors
Brief: Biomx Announces Completion Of Patient Dosing In Part 2 Of The Phase 1B/2A Study Evaluating Bx004 For Treatment Of Chronic Pulmonary Infections In Patients With Cystic Fibrosis
Brief: BiomX Inc Files For Shelf Of Up To 31.8 Mln Shares Of Common Stock By Selling Stockholders
Brief: Biomx Reports First Quarter 2023 Financial Results And Provides Business Update
Brief: BiomX Announces Appointments To Board Of Directors
Brief: Biomx Reports Fourth Quarter And Full Year 2022 Financial Results
Brief: BiomX Announces $7.5 Million Private Placement
Brief: BiomX Announces Positive Results From Part 1 Of The Phase 1B/2A Study Evaluating BX004 For Treatment Of Chronic Pulmonary Infections In Patients With Cystic Fibrosis
Brief: Biomx Reports Q3 Loss of $0.23 Per Share
AMEX RESUMED BIOMX INC UNT
AMEX HALT ADDITIONAL INFORMATION LAST 0.38010
Brief: Biomx reports Q2 results
AMEX RESUMED BIOMX INC UNT